Skip to main content

Table 1 Dose constraints

From: Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

OAR Constraint
Urethra + 2 mm D0.2 cc ≤ 37.5 Gy
Bladder D0.2 cc ≤ 38.5 Gy
  Dmean ≤ 25 Gy
Rectum D0.2 cc ≤ 38.5 Gy
Bowel D0.5 cc ≤ 35 Gy